AI can be applied to patient data in real time, allowing medical reviewer teams to actively monitor patient safety, with the AI alerting medical review teams to identify potential adverse events (AEs), data anomalies, critical issues for patients on treatment, and more.
Related Posts
Accelerating Clinical Trial Activation
Sandra Smith, RN, MSN, AOCN, Senior Vice President, Clinical Solutions and Strategic Partnerships at WCG. Site activation of new clinical…
GSK Presents Positive Results from SWIFT-1 and SWIFT-2, Phase III Trials Evaluating Depemokimab in Adults and Adolescents with Severe Asthma
Image Credit: Adobe Stock Images/Sebastian Kaulitzki GSK announced promising results from its Phase III clinical trials, SWIFT-1 and SWIFT-2, evaluating…
Evaluating the Current State of Randomized Platform Clinical Trials
Image Credit: © photon_photo – stock.adobe.com A study recently published on JAMA Network Open found that a group of randomized…